Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
for Chronic Lymphocytic Leukemia
Drug: Polatuzumab Vedotin
5 locations incl. Atlanta
Sponsor: Christine Ryan
Sex: All·Age: 18+
Code: NCT06043674·Phase 2·Recruiting